Skip to content

Net Income at other companies

Biogen logo
BiogenBIIB
$319.5M+32.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$166.56M+1.8%
Arrowhead Research logo
Arrowhead ResearchARWR
-$132.73M-136%
PTC Therapeutics logo
PTC TherapeuticsPTCT
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT

Segments

By segment

See full
Single Reportable-$105.51M-41.2%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's net income?
Scholar Rock (SRRK) reported net income of -$105.51M in Q1 2026.
How has Scholar Rock's net income changed year-over-year?
Scholar Rock's net income decreased by 41.2% year-over-year, from -$74.72M to -$105.51M.
What is the long-term trend for Scholar Rock's net income?
Over 4 years (2021 to 2025), Scholar Rock's net income has grown at a 30.1% compound annual growth rate (CAGR), from -$131.8M to -$377.94M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.